Skip to main content
Clinical Trials/NCT04041804
NCT04041804UnknownNot Applicable

Activation Intervals Effects on Non-surgical Semi-rapid Maxillary Expansion in Adults

Fundación Universitaria CIEO1 site in 1 country20 target enrollmentStarted: February 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Buccal bone area evaluation

Study Overview

Brief Summary

OBJECTIVE: To evaluate the effects of different time intervals activations on the non-surgical maxillary expansion in adults. Methods: This study will include two groups, 10 adult patients each (mean age 20-35) with maxillary transverse deficiency and unilateral or bilateral crossbite. In the first group, the expansion is going to be activated every four days. In the second group, activation will occur every eight days. The primary outcomes are transverse dimension, the buccal cortical bone formation, and the upper premolar and molar labial inclination. Dentoalveolar changes will be evaluated using CBCT images and digital models.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Presence of transverse maxillary deficiency unilateral or bilateral in which the maxillary cusps of at least two premolars and/or maxillary molars occluded on the central fossa of the antagonist's teeth
  • •The needs of maxillary expansion for the correction of their malocclusion
  • •Age range from 20 to 35
  • •Non-gingivitis or untreated caries at the start of orthodontic treatment
  • •Probing depth less than 4mm across the entire dentition
  • •Gingival index ≤ 1
  • •Plaque index ≤ 1

Exclusion Criteria

  • •Increased Monson curve
  • •Patients with systemic disease
  • •Patients with congenital anomalies
  • •Medicated patients (long term use of antibiotics, Phenytoin, cyclosporine, anti-inflammatory drugs, systemic corticosteroids, and calcium channel blockers)
  • •Pregnancy
  • •Poor oral hygiene for more than two visits
  • •Radiographic evidence of moderate to severe bone loss
  • •Current periodontal disease
  • •Patients who smoke
  • •Individuals with inadequately treated endodontic problems in the study area.

Arms & Interventions

Every four days RPE activation

Active Comparator

Non-surgical semi-rapid maxillary expansion (SRME) with the time intervals activation every four days until getting the require expansion needed

Intervention: semirapid maxillary expansion (SRME) (Procedure)

Every week RPE activation

Active Comparator

Non-surgical semi-rapid maxillary expansion (SRME) with the time intervals activation every week until getting the require expansion needed

Intervention: semirapid maxillary expansion (SRME) (Procedure)

Outcomes

Primary Outcomes

Buccal bone area evaluation

Time Frame: Change from baseline to 6 months

Measure in CBCT in a coronal slice, thickness of the buccal bone in upper first premolars and upper first molars

Transversal distance between upper canines, first premolars and upper first molars

Time Frame: Change from baseline to 6 months

Distance between mesial fosa of each upper canines, first premolars and distance between central fosa of each upper first molars

Posterior teeth buccal inclination

Time Frame: Change from baseline to 6 months

Measure in CBCT in a coronal slice between the palatal plane and the dental axis

Secondary Outcomes

  • Clinical attachment level (CAL)(Change from baseline to 6 months)
  • Bleeding on probing (BP)(Change from baseline to 6 months)
  • Evaluation of the perception of pain by the patient (VAS)(Change from baseline to 6 months)
  • Probing depth (PD)(Change from baseline to 6 months)
  • Soft tissue recession (STR)(Change from baseline to 6 months)

Investigators

Sponsor
Fundación Universitaria CIEO
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sonia Patricia Plaza

Director, Research Orthodontic Department, Principal Investigator.

Fundación Universitaria CIEO

Study Sites (1)

Loading locations...

Similar Trials